A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.
about
Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer.Local treatment of hand-foot syndrome with uridine/thymidine: in vitro appraisal on a human keratinocyte cell line HaCaTApoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancerSalvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthra5-fluorouracil steady state pharmacokinetics and outcome in patients receiving protracted venous infusion for advanced colorectal cancerPhase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancerOxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancerReview article: current treatment and optimal patient management in pancreatic cancer.Cisplatin, tegafur, and leucovorin: a moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck.Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicityThe efficacy of a modified chronomodulated infusion of oxaliplatin, 5-fluorouracil and leucovorin in advanced colorectal cancer (preliminary data).Development of new promising antimetabolite, DFP-11207 with self-controlled toxicity in rodentsA pilot study of mitomycin, cisplatin and continuous infusion 5-fluorouracil (MCF) in advanced non-small-cell lung cancerAdjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study.5-fluorouracil pharmacokinetics: causes for variability and strategies for modulation in cancer chemotherapy.A community-based multicenter trial of pharmacokinetically guided 5-fluorouracil dosing for personalized colorectal cancer therapy5-Fluorouracil derivatives: a patent review.A phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck.Personalized colon cancer care in 2010.The effect of dihydropyrimidine dehydrogenase deficiency on outcomes with fluorouracil.Management of colorectal cancer.Metastatic colorectal cancer: systemic treatment in the new millennium.HFS-14, a specific quality of life scale developed for patients suffering from hand-foot syndrome.Bioavailability and feasibility of subcutaneous 5-fluorouracil.Phase II trial of UFT in advanced colorectal and gastric cancer.A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomas.Altered deoxyuridine and thymidine in plasma following capecitabine treatment in colorectal cancer patients.Pharmacokinetics and bioavailability of oral 5'-deoxy-5-fluorouridine in cancer patients.Continuous 5-fluorouracil in the treatment of breast cancerDouble modulation of 5-fluorouracil with interferon alpha 2a and high-dose leucovorin: a phase I and II study.Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinoma.A phase II study of regional 5-fluorouracil infusion with intravenous folinic acid for colorectal liver metastases.Continuous infusion of 5-fluorouracil with alpha 2b interferon for advanced colorectal carcinoma.The role of chemotherapy in colon cancer.A randomized, phase II trial of standard triweekly compared with dose-dense biweekly capecitabine plus oxaliplatin plus bevacizumab as first-line treatment for metastatic colorectal cancer: XELOX-A-DVS (dense versus standard)A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancerA phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancerWeekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer.Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solution.Combined effect of clinically relevant doses of emitefur, a new 5-fluorouracil derivative, and radiation in murine tumours.
P2860
Q24810562-D15EAB64-9390-40F8-A6AB-77287D1014B1Q28273580-F7B4A685-CF61-4943-8717-1F8D6272CE98Q28346767-019DD724-696D-4F00-B0D9-E3F15BABFF66Q28352371-772003E4-CD2D-41F5-BDD4-FEC82B7099FEQ28359288-35944879-34C9-4475-9E35-FF88C634C2F9Q28361226-B9BF7EE5-4CA9-4580-BBEB-3BAB9B160B83Q28364999-19F60A2B-63BC-4E62-9724-FBABB60D7778Q30431857-1B3F8170-7EE0-40C5-A2A2-12A0CC0EAD24Q33343214-954DB165-F2FC-4AEB-8FAE-B61F3A8D7857Q33367028-856B60E6-5309-458F-B0DE-883DA56C8D8FQ33389163-4F1B8FA3-DAE3-4C9E-8097-0D557EB21DA9Q33442997-302B1876-5D96-4E36-9B0B-F4CE93B2ADE1Q33489857-163BA24A-8403-4240-927F-ECEB55386C65Q33490610-640F21C2-B20A-47F4-816B-32601E40A063Q33750445-38FF8FD7-44EE-4411-9345-2383D16FE8CEQ34127889-1838F5D9-7F49-49CA-9D70-13A3C89935B8Q34253978-D8EE0F33-3B44-4E31-A8A5-EB5D13DF9DCAQ34315576-018B3423-9FAE-4E4F-8E7D-3D7FC1CF799DQ34731381-E97720AE-9014-4B66-A8C5-CBDB6F374C0BQ34761260-0466A96E-42F4-4854-94ED-3DCDC05768F5Q34788235-AF6CDE8D-D920-459D-8905-8FC8A836B804Q35148795-EE12DB3F-2D84-476F-855D-981DF57699A5Q35584405-FEB6E216-EDF5-4CDE-AAA5-C9E703DCF13BQ35976676-7DD1E4BD-C2D6-460C-9056-F7AA5EA1DE96Q35982309-A901B60F-2CDF-4030-A3B5-2BD7F96C6EF2Q35993743-5C3ADF64-7DF3-47D9-B15F-DB0F1B06590CQ36024905-200AE021-1E7C-4DE7-A4EA-42753A11E273Q36053398-6BC1C05B-D9AB-4EBC-BA72-85FB9D18B750Q36079497-56FAD9D8-746E-4E25-B761-BBCBE81B4F6DQ36079721-2AD8B2B3-F757-42BE-85A1-07BFE53242FAQ36079774-7D9D2F2C-B2F5-442C-A35D-397C8C2F502CQ36079784-7C37949F-3DE5-4EB8-9FE2-4FA6A52C89EEQ36081891-659F48CD-BE56-4619-9744-2A5A2CAB29D1Q36101808-2EE8F9DE-8A5E-4AA4-9D24-89B4591A3ACDQ36102819-F42C5FF0-8043-446A-8C94-DA83C6252B02Q36135201-959BE934-647D-4FE7-8A49-A0B0DC0905ADQ36136107-17D88774-B13A-42D5-8526-C579B39DD1AEQ36136402-72F9630F-247D-4F9B-BFDC-EDEBA21EFB75Q36136453-29395B8B-2587-4316-8FF8-FAFA5B895405Q36141244-DF8ED8EE-E175-41F0-BB22-58401C60EE66
P2860
A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
A prospective randomized compa ...... lantic Oncology Program Study.
@en
A prospective randomized compa ...... lantic Oncology Program Study.
@nl
type
label
A prospective randomized compa ...... lantic Oncology Program Study.
@en
A prospective randomized compa ...... lantic Oncology Program Study.
@nl
prefLabel
A prospective randomized compa ...... lantic Oncology Program Study.
@en
A prospective randomized compa ...... lantic Oncology Program Study.
@nl
P2093
P356
P1476
A prospective randomized compa ...... lantic Oncology Program Study.
@en
P2093
J A Philips
J D Ahlgren
J J Lokich
P304
P356
10.1200/JCO.1989.7.4.425
P407
P577
1989-04-01T00:00:00Z